Betulinic acid is a widely available plant-derived triterpene which is reported to possess selective cytotoxic activity against cancer cells of neuroectodermal origin and leukemia. However, the potential of betulinic acid as an antiproliferative and cytotoxic agent on vascular smooth muscle (VSMC) is still unclear. This study was carried out to demonstrate the antiproliferative and cytotoxic effect of betulinic acid on VSMCs using 3-[4,5-dimethylthizol-2- yl]-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometry cell cycle assay, BrdU proliferation assay, acridine orange/propidium iodide staining, and comet assay. Result from MTT and BrdU assays indicated that betulinic acid was able to inhibit the growth and proliferation of VSMCs in a dose-dependent manner with IC 50 of 3.8 g/mL significantly (P<0.05). Nevertheless, betulinic acid exhibited G 1 cell cycle arrest in flow cytometry cell cycle profiling and low level of DNA damage against VSMC in acridine orange/propidium iodide and comet assay after 24 h of treatment. In conclusion, betulinic acid induced G 1 cell cycle arrest and dose-dependent DNA damage on VSMC. © 2012 Raja Kumar Vadivelu et al.
CITATION STYLE
Vadivelu, R. K., Yeap, S. K., Ali, A. M., Hamid, M., & Alitheen, N. B. (2012). Betulinic acid inhibits growth of cultured vascular smooth muscle cells in vitro by inducing G1 arrest and apoptosis. Evidence-Based Complementary and Alternative Medicine, 2012. https://doi.org/10.1155/2012/251362
Mendeley helps you to discover research relevant for your work.